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Treatment effects of fixed functional appliances in patients with Class II 
malocclusion: A systematic review and meta-analysis 
 
SUMMARY 
OBJECTIVE: To assess the treatment effects of fixed functional appliances (FFAs) in treated versus 
untreated Class-II patients by means of lateral cephalometric radiographs.  
SEARCH METHODS: Unrestricted electronic search of 18 databases and additional manual searches 
up to October 2014. 
SELECTION CRITERIA: Prospective randomized and non-randomized controlled trials reporting on 
cephalometric angular measurements of Class-II patients treated with FFAs and their matched control 
patients. 
DATA COLLECTION AND ANALYSIS: Skeletal, dental, and soft tissue cephalometric data were 
annualized and stratified according to the time of evaluation in effects. Following Risk of Bias 
evaluation, the Mean Differences (MDs) and 95% Confidence Intervals (CIs) were calculated with 
random-effects models. Patient- and appliance-related subgroup analyses, and sensitivity analyses 
were performed with mixed-effects models.  
RESULTS: Nine studies were included (418 patients; mean age: 13.2 years) reporting on 
cephalometric effects directly after the removal of FFAs. FFAs were found to induce a small 
reduction of SNA angle (MD=-0.83o/year, 95% CI: -1.17 to -0.48), a small increase of SNB angle 
(MD=0.87o/year, 95% CI: 0.30 to 1.43), and moderate decrease of ANB angle (MD = -1.74o/year, 
95% CI: -2.50 to -0.98) compared to untreated Class-II patients. FFA treatment resulted in significant 
dentoalveolar and soft-tissue changes. Several patient- or appliance-related factors seem to affect the 
treatment outcome. Long-term effectiveness of FFAs could not be assessed due to limited evidence. 
CONCLUSIONS: According to existing evidence, FFAs seem to be effective in improving Class-II 
malocclusion in the short-term, although their effects seem to be mainly dentoalveolar rather than 
skeletal. 
 
The authors declare no conflicts of interest. 
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Introduction  
Rationale 
Class II malocclusion is a frequent condition and a rather common reason for patients seeking 
orthodontic treatment (1, 2). The development of Class II malocclusion could be attributed to several 
factors, hence their accurate diagnosis is important for the selection of the corresponding treatment 
plan. Among these factors, mandibular retrognathism is considered a dominant one (1, 3). In this 
respect, mandibular advancement through the use of functional appliances is considered as a popular 
treatment approach in growing individuals.  
While some researchers posit favourable treatment outcomes based on mandibular growth, 
attributed either as a mandibular length augmentation or effective condyle growth (4–7), others 
dispute the magnitude of these effects (8, 9). Furthermore, a restriction effect on the maxilla has been 
likewise supported by some researchers (10–14) and questioned by others (5, 15). Moreover, existing 
evidence indicates that the dentoalveolar changes produced by functional treatment outweigh the 
skeletal changes attained (13, 15, 16, 17).  
Functional appliances can be categorised into either removable or fixed ones (FFAs). An important 
discriminating factor between them is the need for patient compliance, which is considered to as a 
possible influence on the treatment outcomes (18, 19). As a consequence, it is essential to assess those 
two types of functional appliances separately, in order to investigate their clinical effectiveness and to 
reveal any existing differences. Previously published systematic reviews on the subject presented 
methodological limitations (9, 20–30). The current systematic review on fixed functional appliances 
supplements a previously published systematic review focused exclusively on removable functional 
appliances (17). 
 
Objectives 
This study aims to summarize current evidence only from randomized controlled trials (RCTs) and 
prospective controlled clinical trials (pCCTs) assessing by means of lateral cephalometric radiographs 
the clinical effectiveness of FFAs for the treatment of patients with Class II malocclusion in 
comparison with untreated individuals, as well as to identify any factors affecting the treatment 
outcomes.  
 
Materials and Methods 
Protocol and registration 
The protocol for the present systematic review was constructed a priori according to the Cochrane 
Handbook for Systematic Reviews of Interventions 5.1.0 (31) and is available upon request (no 
registration was performed). The systematic review is reported on the basis of the PRISMA statement 
(32) and its extension for abstracts (33). 
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Information sources and search 
Eighteen electronic databases were systematically and unrestrictedly searched up to November 2011 
and updated in October 2014. In an effort to screen as many eligible articles as possible and not to 
miss any pertinent studies, the search strategy covered initially all functional appliances used for Class 
II treatment (both removable and fixed), and then was cautiously limited to FFAs. MESH terms and 
the respective keywords were used properly to fit each database (Supplementary table 1). The search 
strategy included no limitations concerning language, publication year or status. The reference lists of 
the included trials and relevant reviews were manually searched as well. Grey literature was also 
assessed through proper registers and databases. When considered necessary, authors were contacted 
for complementary data or clarifications. The search was performed independently by two authors 
(VFZ and VK).  
 
Eligibility criteria and study selection 
The eligibility criteria were pre-determined (Table 1). A study was considered eligible when it 
reported on at least one treatment arm with a FFA and simultaneously all of the inclusion and none of 
the exclusion criteria were fulfilled. In order to investigate only the effects of FFAs, data concerning 
any previous or subsequent phases with fixed appliances was not included, since fixed appliances are 
likely to alter the effects caused by functional treatment (30). After the elimination of duplicates, the 
decision for the selection was made by taking into consideration the title, abstract and, when it was 
considered necessary, the full-text of the respective articles. Multiple reports pertinent to the same 
trial/patient cohort were grouped together. When the same trial was published in various languages, 
the English version was preferred. Finally, articles including at least one treatment arm with FFAs 
were selected. 
 
Data collection process and data items 
Data was extracted independently on pre-defined and piloted forms by two authors (VFZ and VK). 
Any ambiguities were resolved after discussion with the last author (MAP). In an effort to investigate 
the clinical effects of FFAs in Class II treatment, only angular cephalometric measurements on lateral 
cephalometric analyses were considered as primary outcomes, due to the fact that linear 
measurements are prone to magnification bias (34, 35). Due to the variability of the terms used among 
the authors for identical variables, all equivalent terms pertaining to the same variable were grouped 
(Supplementary table 2) and one term was used throughout the review.  
If the same variable was reported in at least two included trials, the respective data were extracted 
and categorised as skeletal (sagittal and vertical), dental, and soft tissue variables. Reported outcomes 
were stratified based on the time of evaluation in effects: (a) after the removal of the corresponding 
FFA and (b) after the retention phase.  
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Several factors were determined a priori to be investigated via subgroup analyses for their possible 
effect on the FFA treatment outcomes, if at least five studies reported on the corresponding factor. 
These factors were divided to patient-related (i.e. specific patients’ characteristics) and appliance-
related (i.e. specific features of the appliance design or the treatment plan). The patient-related factors 
involved (a) patient gender ratio (male patients/female patients), (b) patients’ skeletal growth stage 
(pre-peak and peak or post-peak), and (c) patients’ growth pattern (horizontal, vertical, or average). 
The discrimination between the various stages of skeletal maturation relied exclusively on the cervical 
vertebral maturation index or on hand-wrist radiographs, which are considered as efficient methods 
for the identification of skeletal age (36, 37). Studies providing data concerning only the 
chronological and/or dental age of the patients were excluded from the evaluation of skeletal maturity, 
since these methods are not considered reliable for the discrimination of skeletal growth stages (38, 
39). If the growth pattern was clearly stated in the included articles, then it was categorised 
accordingly. When no such data was available, the discrimination was based on the mean values of 
either the SN-ML or FH-ML angles, as reported on the patients’ baseline characteristics.  
Further, the appliance-related factors included (a) appliance used (i.e. the exact type and design of 
the respective appliance) and (b) construction bite (single step vs. stepwise mandibular advancement).  
 
Risk of bias in individual studies 
The Cochrane Collaboration’s tool (31) and a modified Downs and Black checklist (40) were used to 
assess the risk of bias in RCTs and pCCTs, respectively. The overall risk of bias was judged as 
"high", "low" or "unclear" for randomized studies, while serious methodological limitations were 
judged to exist when a pCCT collected less than 17 points on the modified checklist (41). 
 
Risk of bias across studies 
If a sufficient number of trials were identified (n >10) reporting biases (small-study effects or 
publication bias) were planned to be assessed through the inspection of a contour-enhanced funnel 
plot (42), Begg’s rank correlation test (43) and Egger’s weighted regression test (44). If the tests 
hinted towards the existence of publication bias, the Duval & and Tweedie’s trim and fill procedure 
(45) was planned to be performed. 
The overall quality of evidence (confidence in effect estimates) for each of the main outcomes was 
rated by using the Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) 
approach (46).  
The minimal clinical important, large, and very large effects were conventionally defined (47) as 
half, one, and two standard deviations of the Caucasian cephalometric norm plus 1°, respectively, to 
allow for method error. The optimal information size (i.e. required meta-analysis sample size) was 
calculated for each outcome independently for α = 5% and β = 20%. 
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The search strategy, study selection, data extraction, and within-studies risk of bias assessment 
were performed independently without blinding (48) by two review authors (VFZ and VK), across-
studies risk of bias assessment by a third author (SNP), and any disagreement was resolved by 
discussion with the last author (MAP). Authors were contacted when necessary to resolve ambiguities 
or provide complementary data. Inter-reviewer agreement for the three stages was evaluated with the 
un-weighted Cohen’s kappa (49). 
 
Summary measures and synthesis of results 
Data were summarised and considered suitable for pooling if similar control groups of untreated Class 
II patients were used and if the same cephalometric angular outcomes were reported. In an effort to 
account for the different follow-up periods of the included studies, the treatment and the observational 
changes were annualized. Mean Differences (MDs) and their corresponding 95% Confidence 
Intervals (CIs) were calculated. The random-effects model as proposed by DerSimonian and Laird 
(50) was chosen a priori as the primary method to estimate all pooled estimates, appropriately 
supported by both clinical and statistical reasoning (51), as described previously (17). The extent and 
impact of between-study heterogeneity was assessed by inspecting the forest plots and by calculating 
τ2 and the I² statistics, respectively. The 95% CIs around I2 were calculated according to the non-
central χ2 approximation of Q (52). For meta-analyses with ≥ 3 trials, 95% Prediction Intervals (PI) 
(53, 54) were calculated to quantify of treatment effects of FFAs in a future trial. 
All P values were 2-sided with α = 5%, except for the test of between-studies or between-
subgroups heterogeneity (α = 10%) (55). 
 
Additional analyses 
Possible sources of heterogeneity in meta-analyses with 5 or more studies were sought through pre-
specified mixed-effects subgroup analyses and random-effects meta-regression with the Knapp-
Hartung adjustment (56). 
Robustness of the results was a priori to be checked with sensitivity analyses based on (a) the 
duration of the FFA treatment, (b) the method error of the cephalometric analysis (where reported), 
and (c) the improvement of the GRADE classification.  
 
Results 
Study selection 
From the initially identified 9115 records, 6342 remained after exclusion of duplicates and 6087 
additional records were excluded on the basis of screening (Table 2). A total of 255 full texts were 
assessed for eligibility (Figure 1), with 10 articles (57–66) having at least one treatment arm with a 
FFA and being included in the systematic review. Two articles reported (59, 60) data from the same 
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study/cohort and were grouped together. Thus, 9 unique datasets were finally included in the 
qualitative and quantitative synthesis of this systematic review. In total, 2 authors were contacted; one 
of them responded, while the other one did not respond (communication details available upon 
request). The kappa scores before reconciliation for the selection, data extraction, and risk of bias 
assessment procedures were 0.855, 0.923, and 0.891, respectively (with asymptotic standard errors 
0.103, 0.088, and 0.97), indicating almost perfect agreement. 
 
Study characteristics and risk of bias within studies 
The characteristics of the 10 included studies (9 datasets) are presented in Table 3. Seven of them took 
place at a university, one at a military academy, and one at a private practice, including a total of 418 
subjects with a mean age of 13.2 years. The majority of the patients were treated with the original 
design of the corresponding FFA, while in two studies the FFAs were either modified or incorporated 
additional elements for maxillary expansion. All included studies provided data on skeletal and 
dentoalveolar changes, while five reported additionally on soft tissue cephalometric outcomes. 
According to the Cochrane Collaboration’s tool, the only one RCT identified (58) was judged to be 
in high risk of bias (Supplementary table 3a). The eight pCCTs (57, 59–66) scored an average of 22.4 
points on the modified Downs and Black tool, which are actually not much, while none of them was 
considered to present serious methodological limitations (Supplementary table 3b).  
 
Results of individual studies, synthesis of results and risk of bias across studies 
A) Effectiveness of FFA treatment directly after appliance removal 
Meta-analyses could be performed regarding only the short-term effectiveness of FFAs (i.e. from the 
time point of placement of the corresponding FFAs until immediately after their removal) compared 
to natural growth (as indicated by the data of the untreated control individuals) for 24 cephalometric 
variables, including eleven skeletal (five sagittal and six vertical), six dental, four soft tissue variables 
and three ratios (Table 4). In short, many skeletal, dental, and soft tissue variables were found to be 
significantly affected by FFA treatment. 
With regard to the skeletal changes in the sagittal plane, the skeletal growth of the mandible was 
slightly affected by FFAs, with the SNB angle being on average 0.87° per year greater than the 
untreated group (Figure 2). Further, a statistically significant slight restriction effect on the maxillary 
growth of about 0.83° per year was induced by FFAs. The effect of FFAs on the skeletal relationships 
of the maxilla to the mandible was favourable, with the ANB angle being on average 1.74° decreased 
annually (P < 0.001) compared to the untreated group, indicating a moderate improvement of the 
skeletal Class II jaw relationships. Finally, as far as the vertical skeletal relationships are concerned, 
no significant effects could be found, except for annual increases of the SN-ML and SN-OP angles by 
0.48° and 10.09° per year, respectively). The later indicates a clinically significant effect on the 
inclination of the occlusal plane during mandibular advancement.  
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With regard to the dentoalveolar changes, treatment effects were evident on all variables 
corresponding to the upper and lower dental arches. Significant retroclination of the upper incisors 
was observed compared to the untreated group, as seen from the 1s-SN (-7.50° per year) and 1s-NA 
angle (-4.24° per year). Additionally, the lower incisors were significantly proclined, as seen from the 
1i-ML (7.99° per year), 1i-NB (4.20° per year), and 1i-VL angle (19.78° per year). Consequently, a 
statistically significant decrease in the interincisal angle was also noted (-8.32° per year).  
The influence of FFAs on the soft tissues was significant for almost all available outcomes, with 
the mentolabial angle providing the more evident change (14.99° per year). Further, the H-angle was 
slightly decreased (-1.95° per year), while the N΄SnPg΄ angle was slightly increased (2.01° per year) 
compared to untreated patients. Finally no significant changes were observed regarding the 
cephalometric ratios investigated. 
 
Risk of bias across studies 
The GRADE assessments for the main outcomes after appliance removal ranged from low to high 
(Table 5). The quality of clinical recommendations was upgraded due to the magnitude of treatment 
effects for the upper incisor retroclination (via the 1s-SN angle) and the proclination of the 
mandibular incisors (via the 1i-ML angle). All judgements made for the GRADE analysis of each 
outcome are presented in detail in Supplementary table 4. 
 
Additional analyses 
The results of the included studies varied considerably and heterogeneity influenced the results of 
FFAs according to various patient-related factors (Table 6). Skeletal correction and facial convexity 
(via the ANB and NA-APg angles respectively) were significantly associated with patient sex. Post-
peak patients showed a greater dentoalveolar effect with a greater emphasis on SN-NL and 1i-ML 
angles, and a greater reduction in 1s-SN angle compared with patients at pre-peak and peak skeletal 
growth stage. Finally, the impact of growth pattern on the treatment outcome was planned to be 
assessed, yet was not possible due to insufficient data reported in the included trials. 
With regard to the appliance-related factors, for mandibular sagittal growth (via the SNB angle) 
and skeletal Class II correction (via the ANB angle) no statistical differences were observed, whereas 
the ForsusTM Fatigue Resistant Device was associated with the greatest proclination of the mandibular 
incisors. In addition, stepwise mandibular advancement was associated with greater retroclination of 
the upper incisors and greater proclination of the lower incisors compared to single step advancement.  
Due to the limited number of included studies, it was not possible for an evaluation for the 
existence of reporting bias (including publication bias) to be performed. 
Sensitivity analysis on the basis of treatment duration (Supplementary table 5) indicated that the 
duration of FFA treatment was significantly associated with the inclination of the upper and the lower 
incisors (via the 1s-SN and 1i-ML angles, respectively). Furthermore, the sensitivity analysis based on 
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the design of the included studies (Supplementary table 6) found no statistically significant 
differences between pCCTs and RCTs for the investigated angular measurements. Sensitivity analysis 
on the basis of the reported method error for each outcome could not be performed, due to incomplete 
reporting from the included studies. Finally, sensitivity analyses on the basis of the GRADE quality of 
recommendations were not feasible, as the only reason for downgrading the quality of 
recommendations was the inclusion of pCCTs over RCTs. 
 
B) Effectiveness of FFA treatment after retention 
Due to inadequate number of identified studies, no meta-analyses could be performed concerning the 
changes induced by FFAs after the retention phase. 
 
Discussion 
Summary of evidence 
This systematic review included data from 418 patients and 10 RCTs and pCCTs, which assessed 
angular cephalometric changes induced by Class II treatment with FFAs. With regard to the ANB 
angle, the results from the random-effects meta-analyses indicated that FFAs had a statistically 
significant contribution in the improvement of skeletal Class II relationship (as seen by the average 
annualized decrease of 1.74o of the ANB angle of the treated patients in comparison to untreated 
controls). This improvement was accomplished with approximately equal contributions from 
mandibular growth augmentation (0.87o per year) and restriction of maxillary growth (0.83o per year). 
However, the skeletal contribution in the sagittal plane to the correction of Class II malocclusion can 
be considered clinically small, in concordance with previous studies (8, 14, 15). Furthermore, in 
agreement with previous findings (67–69), the FFA treatment was associated with a significant 
increase of inclination of the occlusal plane relative to anterior cranial base. 
The effects of FFAs were more pronounced on the dentition, where the maxillary incisors were 
significantly retroclined and the mandibular incisors were significantly proclined, resulting, thus, in a 
greater interincisal angle, agreeing with previous evidence (13, 69–71). Contradictory results 
regarding the effect of FFAs on soft tissues have been reported (13, 23, 69, 72). Based on the results 
of this study, soft tissues were significantly affected in favour of profile improvement by FFAs. 
Finally, no significant changes were observed in the investigated cephalometric ratios.  
Several patient-related factors might explain the considerable variation in the treatment outcome 
among the included studies. The impact of patient’s sex on the respective treatment could not be 
formally assessed in this study with separate sub-populations of male and female patients, due to the 
incomplete reporting of data in the original articles. The results of the meta-regression with the 
male/female ratio from each study indicate that the Class II correction and the skeletal facial 
convexity (through the ANB and NA-APg angles respectively) directly after the appliance removal 
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might be different between boys and girls, but further research is required to confirm or refute this. 
However, in a retrospective study, Rizell et al., (73) failed to identify a statistically significant 
association between gender and outcome of functional treatment. 
The investigation of the patients’ growth pattern and its influence on the FFA treatment results was 
originally planned but was not possible, due to the lack of data. 
When the skeletal growth stage is taken into account, outcomes of FFA treatment were found to 
differ between patients before or during and patients after the growth peak. According to a previous 
study, dentoalveolar effects seem to increase in post-peak patients (74). Moreover, skeletal effects 
seem to be more pronounced in patients treated before (74, 75) or during the growth peak (8). The 
results of the present study indicate a trend towards more favourable skeletal sagittal changes in the 
pre-peak/peak than in the post-peak growth stage, although no statistical inference could be 
confirmed. 
With regard to appliance-related factors, considerable differences were found among the seven 
different FFAs used in the included studies. Among them, the ForsusTM Fatigue Resistant Device was 
associated with the greatest proclination of the lower incisors (via the 1i-ML angle). A comparison of 
the effectiveness of the included FFAs is presented in Supplementary figures 1-3 regarding three 
skeletal variables and in Supplementary figures 4 and 5 regarding two dentoalveolar variables. 
However, these comparisons should be interpreted with caution due to the presence of considerable 
heterogeneity and their indirect nature. In a comparative evaluation of the ForsusTM Nitinol Flat 
Spring and the Jasper Jumper (15), the superiority of the latter in advancing the mandible was 
reported. Finally, contrary to the present study, a previous systematic review (8) reported that the 
Herbst appliance was found to produce more favourable results in matters of increased mandibular 
growth compared to other functional appliances. However, only the Herbst and the Mandibular 
Anterior Repositioning Appliance appliance were included from FFAs, while no quantitative synthesis 
was conducted. 
The three different designs of the Herbst appliance that were used in the included studies were 
compared separately, with some significant differences among them (Table 5). Burkhardt et al., (76) 
compared acrylic-splint and stainless-steel crown Herbst and reported that both the appliances 
produced similar skeletal changes. According to a previous assessment of the efficacy of three 
different Herbst anchorage systems (77), greater lower incisor proclination was observed with the 
cast-splint design than in the banded designs, although none of the designs could prevent mandibular 
anchorage loss. In the last years, attempts have been made to prevent anterior anchorage loss during 
mandibular protraction by utilising miniscrew implants, without however, particular success (78). 
Moreover, the comparison between stepwise activation and maximum mandibular advancement did 
not reveal any significant differences, with the exception of the greater maxillary incisor retroclination 
that was observed with the former. Contrary to these results, a controlled trial investigating the effects 
of the Herbst appliance (72), reported that stepwise mandibular advancement produced greater 
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skeletal changes compared to single step advancement, while the dentoalveolar changes were more 
pronounced when the activation was performed at a single step. 
 
Strengths and limitations 
The strengths of the present review include the pre-defined protocol, the thorough and unrestricted 
literature search, and the strict methodology that was carefully followed during every stage of it 
following specific and detailed guidelines (31–33, 46). In addition, the 10 included studies enabled 
adequately-powered meta-analyses for many important treatment outcomes, for which the required 
meta-analysis sample size was fulfilled almost exclusively. Since a random-effects model was used 
for data synthesis, the results of the present study provide the average of the FFA effects across the 
included studies. Heterogeneity was explained in most cases by the pre-defined subgroup analyses, 
while sensitivity analyses indicated that the results were fairly robust. In addition, data from a 
minimum of five studies was considered as adequate to perform a subgroup analysis, in order to 
minimize multiple testing. Although most of the included trials took place at university settings, their 
findings could possibly be generalized to the average patient, due to their broad inclusion criteria. 
Finally, the vast majority of the included trials (89%) were pCCTs, which represent more “realistic” 
situations in matters of the daily clinical practice, compared to RCTs, and thus possibly strengthening 
the applicability of the outcomes.  
Nevertheless, although no serious methodological limitations were found in the included original 
studies, their quality could have been better. Moreover, none of the included studies provided results 
concerning the number and the experience of the respective clinicians, which could introduce 
proficiency bias (79). Unfortunately, treatment results concerning the long-term effects of FFAs were 
not reported in the selected studies, precluding an assessment of the results’ stability in current 
evaluation. Finally, the limited number of the eligible studies prevented the investigation of all the 
originally planned patient- and appliance-related factors in this review, while reporting biases could 
not be formally assessed (80). 
 
Conclusions 
According to existing evidence, the following conclusions can be drawn on the short-term 
effectiveness of FFAs: 
 The treatment effects of FFAs on the skeletal tissues in patients with Class II malocclusion 
excluding the effects of normal growth, were small and probably, of minor clinical importance. 
 The treatment of Class II malocclusion with FFAs was associated with small stimulation of 
mandibular growth, small inhibition of maxillary growth, and with more pronounced 
dentoalveolar and soft tissue changes. 
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 Patient- and appliance-related factors seem to influence the treatment outcomes, yet 
complementary research is required to thoroughly investigate the respective effects. 
 The long-term effects of FFAs could not be properly assessed, because of insufficient number of 
relative trials at present. 
 
Taking into account the clinical recommendations derived from the GRADE framework, high 
GRADE assessments could be drawn regarding the 1s-SN and 1i-ML angles exclusively. Particularly: 
 Clinicians should confidently expect an average reduction in the 1s-SN angle of 7.50° per year 
with the use of FFAs compared to untreated patients with the use of FFAs. 
 Clinicians should confidently expect an average increase in the 1i-ML angle of 7.99° per year 
with the use of FFAs compared to untreated patients. 
Recommendations concerning the effectiveness of FFA treatment on the restriction of maxillary 
growth, advancement of the mandible, correction of skeletal Class II malocclusion, mandibular plane, 
and nasolabial angles are weaker and future research could affect them. 
 
Treatment of Class II malocclusion with FFAs seems to be not as effective as believed in matters of 
skeletal correction. Additional studies are required for a thorough assessment of the skeletal, dental, 
and soft tissue outcomes of FFAs in the long-term. The provision of detailed data from these studies 
regarding patients’ characteristics (gender, growth pattern, skeletal maturation), particular features of 
the used functional appliance (the exact appliance design and possible incorporation of additional 
elements), as well as the followed retention scheme should be considered. Finally, in order to enable 
also the assessment of linear variables, the magnification factor of the lateral cephalometric 
radiographs should be reported in each of the respective trials.  
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Figure legends  
 
Figure 1. PRISMA flow diagram for the selection of studies. 
 
 
 
  21 
Figure 2. Forest plot of the mean difference of the SNA, SNB, and ANB angles (in °/year) between 
FFAs and control groups based on the random-effects model together with the 95% confidence 
interval and the 95% prediction interval. Studies on the right indicate that fixed functional treatment 
results in decreased SNA angle/increased SNB angle/decreased ANB angle compared to the normal 
growth, while studies on the left indicate increased SNA angle/decreased SNB angle/increased ANB 
angle compared to the normal growth. 
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Tables 
 
Table 1. Eligibility criteria used for the study selection. 
 
 
 
 
 
Category Inclusion criteria Exclusion criteria 
Participant 
characteristics 
Studies on human patients with Class II 
malocclusion of any age or sex 
 
Patients with craniofacial syndromes and/or cleft lip palate 
Patients with temporomandibular joint disorders 
Animal studies 
 
Intervention 
Orthodontic treatment with fixed 
functional appliances  
 
Patients with Class II malocclusion treated with extractions, Class II 
elastics, orthognathic surgery or removable functional appliances  
 
Comparison 
 
Untreated patients with Class II 
malocclusion matched for age and 
gender 
 
Studies without an untreated Class II control group 
Outcome 
 
Studies providing angular skeletal, 
dentoalveolar and soft tissue 
cephalometric measurements from 
lateral cephalometric analysis 
Studies providing only linear cephalometric measurements 
Electromyographic evaluation 
Evaluation employing 3D imaging techniques 
Cost benefit analysis 
 
Study design 
Randomized controlled clinical trials 
Prospective controlled clinical trials 
Unsupported opinion of expert 
Editor’ s choices 
Replies to the author / editor 
Interviews 
Commentaries 
Books’ / Conferences’ abstracts 
Summaries 
Cross-sectional surveys 
Case series without a control 
Case reports or reports of cases 
Case-control observational studies 
Cohort studies 
Retrospective clinical trials 
Narrative reviews* 
Systematic reviews* 
Meta-analyses* 
*After checking the reference lists for relevant papers. 
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Table 2. Number of excluded studies with reasons. 
Reason for exclusion Excluded articles on the basis of title and abstract Excluded articles on the basis of full-text  
Animal studies 1 1 
Patients treated with extractions, Class II elastics or orthognathic surgery 89 8 
Studies without or inappropriate comparison group 144 73 
Investigation not relevant to the subject of this study 5604 39 
Evaluation employing 3D imaging techniques 7 6 
Books’ / Conferences’ abstracts 72 – 
Cross-sectional surveys 4 – 
Case reports or reports of cases 62 – 
Retrospective clinical trials 68 80 
Narrative reviews 9 – 
Systematic reviews 23 – 
Meta-analyses 4 – 
Ongoing studies – 2 
No angular cephalometric measurements  – 10 
Removable functional appliances  – 22 
No discrimination between treatment with fixed functional appliances and 
fixed orthodontic appliances 
– 4 
Sum 6087 245 
 
 
 
 
. 
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Table 3. Characteristics of the studies included in the current systematic review. CCT†, prospective controlled trial with historical control; CCT, prospective controlled trial; 
RCT, randomized controlled trial; Gp1/2, treatment group; Ctr, control group; ME, maxillary expansion; M/F, males/females; m, months; NR, not reported. 
A/A Study  Design Setting Characteristics of patients Interventions 
No. of patients 
(M/F) 
Age in years 
(SD) 
Skeletal 
growth 
stage 
Treatment 
time*** 
(m) Outcomes 
Risk of 
bias  
Conflict 
of 
interest 
1 Alali, (57) CCT 
University; 
Syria 
Class II/1 malocclusion, overjet > 
4 mm, ANB > 4º and APg/NL < 
80º, SNB < 76º, pubertal growth 
spurt peak 
Fixed lingual 
mandibular 
growth 
modificator 
Gp: 21 (10/11) 
Ctr: 17 (7/10) 
Gp: 13.2 (0.9) 
Ctr: 12.5 (2.1) 
Peak 
Gp: 18.2  
Ctr: 17.9 
Skeletal 
Dental 
16 NR 
2 
Baysal and 
Uysal, (58) 
RCT 
University; 
Turkey 
ANB > 4°, SNB < 78°, overjet ≥ 5 
mm, SN-GoGn 32° ± 6°, 
crowding in dental arches ≤ 4 
mm, bilateral Class II molar and 
canine relationship ≥ 3.5 mm 
Cast splint Herbst 
(ME) 
Gp: 20 (9/11) 
Ctr: 20 (11/9) 
Gp: 12.7 (1.4) 
Ctr: 12.2 (1.5) 
Pre-peak 
and peak 
Gp: 15.8  
Ctr: 15.6  
Skeletal 
Dental 
Soft tissue 
High 
risk 
Internal 
3 
de Almeida 
et al., (59) 
and de 
Almeida et 
al., (60) 
CCT† 
University; 
Brazil 
Class II/1 malocclusion with 
bilateral distal molar relationship 
> one-half cusp, presence of 
mandibular deciduous second 
molars, ANB ≥ 4.5° 
Herbst (modified) 
Gp: 30 15/15)* 
Ctr: 30 (15/15) 
Gp: 9.8 (NR)** 
Ctr: 9.7 (NR) 
Pre-peak 
and peak 
Gp: 12.0 
Ctr: 12.0 
Skeletal 
Dental 
Soft tissue 
23 NR 
4 
Gunay et al., 
(61) 
CCT† 
University; 
Turkey 
Skeletal and dental class II 
malocclusion due to retrognathic 
mandible, normal or low-angle 
growth pattern, postpeak growth 
period, no extracted or 
congenitally missing permanent 
teeth, minimum crowding in the 
lower dental arch 
Forsus FRD 
Gp: 15 (6/9) 
Ctr: 12 (3/9) 
Gp: 15.0 (1.2) 
Ctr: 14.1 (1.4) 
Post-
peak 
Gp: 5.3 
Ctr: 6.0 
Skeletal 
Dental 
Soft tisue 
18 NR 
5 
Karacay et 
al., (62) 
CCT 
Military 
Medical 
Academy; 
Turkey 
Active growth period, normal or 
mildly prognathic maxilla, 
retrognathic mandible, horizontal 
or normal growth pattern, class II 
molar relationship, overjet < 7 
mm, minimum crowding, 
permanent dentition 
Gp1: Forsus 
nitinol flat spring  
Gp2: Jasper 
jumper 
Gp1: 16 (9/7) 
Gp2: 16 (10/6) 
Ctr: 16 (NR) 
Gp1: 13.6 (1.2) 
Gp2: 14.0 (1.9)  
Ctr: 13.8 (1.4) 
NR 
Gp1: 5.3 
Gp2: 5.2 
Ctr: 6.0 
Skeletal 
Dental 
22 NR 
6 
Latkauskienė
, (63) 
CCT† 
University; 
Lithuania 
≥ end-to-end Class II molar 
relationship bilaterally or more 
severe, permanent dentition, no 
active hard tissue lesions, no 
previous orthodontic treatment or 
tooth extractions, no bone level 
problems, no TMJ complaints, no 
tooth size, form, and number 
anomalies, no facial development 
Stainless steel 
crown Herbst 
Gp: 40 (20/20) 
Ctr: 18 (11/7) 
Gp: 13.6 (1.3) 
Ctr: 13.9 (1.6) 
Peak and 
post-
peak 
Gp: 12.0 
Ctr: 12.0 
Skeletal 
Dental 
25 NR 
  25 
or mental syndroms, no pregnancy 
7 
Oztoprak et 
al., (64) 
CCT† 
University; 
Turkey 
Class II malocclusion due to 
retrognathic mandible, SN-MP = 
25°-35°, post-peak growth period, 
no extracted or congenitally 
missing permanent teeth, 
minimum crowding in the lower 
arch 
Gp1: Sabbagh 
universal spring 
Gp2: Forsus FRD 
Gp1: 20 (9/11) 
Gp2: 20 (8/12) 
Ctr: 19 (5/14) 
Gp1: 15.3 (1.2) 
Gp2: 15.1 (1.0) 
Ctr: 14.8 (1.3) 
Post-
peak 
Gp1: 5.2 
Gp2: 5.2 
Ctr: 6.0 
Skeletal 
Dental 
Soft tissue 
23 NR 
8 
Phelan et al., 
(65) 
CCT† 
Private 
practice; 
Germany 
Class II/1 malocclusion of a half 
or full cusp, overjet ≥ 6 mm, ANB 
> 3.5°, and nonextraction 
treatment plan 
Sydney 
magnoglide 
Gp: 31 (19/12) 
Ctr: 30 (15/15) 
Gp: 13.5 (1.2) 
Ctr: 13.0 (1.6) 
Pre-
peak, 
peak, 
and 
post-
peak 
Gp: 12.0  
Ctr: 12.0 
Skeletal 
Dental 
22 
External; 
non 
profit 
9 
Uyanlar et 
al., (66) 
CCT 
University; 
Turkey 
SNB < 80°, SN-ML ≤ 32°, post-
peak growth period, no extracted 
or congenitally missing permanent 
teeth, minimum crowding in the 
lower dental arch 
Sabbagh universal 
spring 
Gp: 15 (7/8) 
Ctr: 12 (3/9) 
Gp: 15.2 (1.1) 
Ctr: 14.1 (1.4) 
Post-
peak 
Gp: 5.2 
Ctr: 6.0 
Skeletal 
Dental 
Soft tissue 
19 NR 
*Only for soft tissue measurements Gp: 29 (15/14) and Ctr: 28 (14/14). 
**Only for soft tissue measurements Gp: 9.9 (NR). 
***Control group received no intervention; it refers to the observation time.
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Table 4. Details of the performed meta-analyses with tests on heterogeneity. FA, functional appliance group; Ctr, control group; MD, mean difference; CI, confidence 
interval; PI, prediction interval; NA, not applicable. 
      Effect Size  Heterogeneity 
No. Variable Studies Post-Pre in FA* Post-Pre in Ctr*  MD 95% CI P-Value 95% PI  P-Value τ2 I2 (95% CI) 
1 SNA 9** (-0.57) (0.13)  -0.83 -1.17,-0.48 <0.001 -1.58,-0.08  0.202 0.069 27% (0%,66%) 
2 SNB 9** (1.07) (0.11)  0.87 0.30,1.43 0.003 -0.84,2.57  <0.001 0.435 72% (32%,84%) 
3 SN-Pg*** 2 (1.45) (0.24)  1.29 -0.52,3.09 0.162 NA  <0.001 1.588 94% (NA) 
4 ANB**** 9** (-1.95) (-0.13)  -1.74 -2.50,-0.98 <0.001 -4.30,0.82  <0.001 1.019 87% (78%,92%) 
5 NA-Apg**** 5** (-3.01) (-0.96)  -1.86 -5.06,1.34 0.254 -13.68,9.95  <0.001 11.120 90% (78%,94%) 
6 SGo:Nme (%) 4** (1.31) (1.29)  0.71 -0.09,1.51 0.080 -1.04,2.46  0.424 0.000 0% (0%,68%) 
7 SN-ML 8** (0.16) (-0.43)  0.48 0.04,0.92 0.031 -0.07,1.03  0.949 0.000 0% (0%,56%) 
8 NL-ML 2** (0.28) (0.15)  0.13 -0.95,1.20 0.818 NA  0.776 0.000 0% (NA) 
9 SN-NL 6** (0.41) (-0.29)  0.54 -0.23,1.32 0.168 -1.30,2.39  0.181 0.284 34% (0%,73%) 
10 SN-OP 4** (8.44) (-1.58)  10.09 7.22,12.96 <0.001 -0.96,21.13  0.099 4.442 52% (0%,82%) 
11 y axis*** 2** (3.65) (0.34)  3.06 -2.18,8.29 0.252 NA  0.002 12.881 90% (NA) 
12 1s-SN**** 6** (-6.49) (0.93)  -7.50 -10.88,-4.11 <0.001 -18.32,3.33  <0.001 12.209 79% (44%,89%) 
13 1i-ML**** 9** (8.20) (0.25)  7.99 3.56,12.42 <0.001 -8.34,24.32  <0.001 42.595 96% (95%,97%) 
14 1s-1i***** 3** (-4.59) (-1.48)  -8.32 -13.38,-3.25 0.001 -57.04,40.41  0.190 8.038 40% (0%,82%) 
15 1s-NA 2 (-3.38) (1.16)  -4.24 -6.09,-2.40 <0.001 NA  0.233 0.572 30% (NA) 
16 1i-NB 2 (4.60) (0.36)  4.20 2.48,5.91 <0.001 NA  0.195 0.684 40% (NA) 
17 1i-VL 3** (18.67) (-1.13)  19.78 15.50,24.06 <0.001 -24.38,63.94  0.129 7.319 51% (0%,85%) 
18 N΄SnPg΄ 2 (1.88) (-0.19)  2.01 1.05,2.96 <0.001 NA  0.622 0.000 0% (NA) 
19 Nasolabial angle 5** (0.49) (0.49)  0.03 -2.39,2.45 0.979 -4.83,4.89  0.347 0.802 10% (0%,68%) 
20 Mentolabial angle 2 (10.00) (-5.19)  14.99 8.09,21.88 <0.001 NA  0.233 7.337 30% (NA) 
21 H angle 4** (-2.14) (-2.01)  -1.95 -3.16,-0.74 0.002 -4.61,0.70  0.908 0.000 0% (0%,68%) 
22 ANSMe:Nme****** 3** (0.89) (0.63)   omitted        
23 Gonial Ratio 3** (1.99) (0.23)   1.62 -0.66,3.90 0.164 -23.17,26.41  0.080 2.452 60% (0%,87%) 
24 S-Ar/Ar-Go 2** (-3.86) (-4.77)  0.49 -3.48,4.46 0.809 NA  0.667 0.000 0% (NA) 
*Results from random-effects meta-analysis of the post-pre differences in each group to provide an overview of the effect's direction. 
**Pooled trial arms included. 
***High heterogeneity identified; however, our confidence in the calculation of heterogeneity is limited, due to the small number of studies. Furthermore, it would affect only the 
estimation of the effect magnitude; not its direction (i.e. all studies lie on the same side of the forest plot). 
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****High heterogeneity identified; however, heterogeneity is explained by differences between subgroups. Caution is warranted on the interpretation of the overall effect estimate; 
estimates for subgroups are to be preferred. 
*****Initial analysis included four studies (MD=-3.14; 95% CI=-15.95 to 9.67; P=0.631; τ2=160.559; I2=95%), but the study Alali, (57) (fixed lingual mandibular growth modificator) 
was omitted to achieve homogeneity. 
******High heterogeneity identified, which remained unexplained; meta-analysis of three studies (MD=0.13; 95% CI=-2.17,2.42; P=0.915; τ2=3.472; I2=85%) omitted, as studies were 
distributed on both sides of the forest plot and elimination of a single study was not straightforward. 
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Table 5. GRADE summary of findings table for the main outcomes of the systematic review directly after treatment with fixed functional appliances. CI, confidence 
interval; Ctr, untreated control group; mo, month; FFA, fixed functional appliance. 
Patients: receiving orthodontic treatment to improve Class II malocclusion 
Settings: university clinics (Brazil, Lithuania, Syria, Turkey), private practice (Germany), and military academy (Turkey) 
Intervention: FFAs (Fixed Lingual Mandibular Growth Modificator, Forsus Fatigue Resistant Device, Forsus Nitinol Flat Spring, Herbst, Jasper Jumper, Sabbagh Universal Spring, Sydney 
Magnoglide) 
Comparison: untreated patients from follow-up or historical controls 
Outcomes 
Illustrative comparative risks (95% CI) 
No. of patients 
(trials) 
Quality of 
evidence 
(GRADE) Comments 
Assumed risk Corresponding risk 
Untreated (Ctr) patients FFA patients 
Annualized SNA change from 
baseline (follow-up: 5.2–15.8 
mos)* 
The SNA increased on average by 
0.13° per year in the Ctr groups 
(range -0.52° to 0.80°) 
The mean SNA decreased in the FFA groups 
by 0.83° per year (95% CI: 0.48°–1.17° 
decrease) compared to the Ctr groups 418 (9) 
⊕⊕⊖⊖ 
Low 
– 
Annualized SNB change from 
baseline (follow-up: 5.2–15.8 
mos)* 
The SNB increased on average by 
0.11° per year in the Ctr groups 
(range -0.30° to 1.16°) 
The mean SNB increased in the FFA groups 
by 0.87° per year (95% CI: 0.30°–1.43° 
increase) compared to the Ctr groups 418 (9) 
⊕⊕⊖⊖ 
Low 
Effect magnitude affected 
by appliance 
Annualized ANB change from 
baseline (follow-up: 5.2–15.8 
mos)* 
The ANB decreased on average by 
0.13° per year in the Ctr groups 
(range -1.26° to 0.60°) 
The mean ANB decreased in the FFA 
groups by 1.74° per year (95% CI: 0.98°–
2.50° decrease) compared to the Ctr groups 418 (9) 
⊕⊕⊖⊖ 
Low 
Effect magnitude affected 
by (i) patient’s gender and 
(ii) appliance 
Annualized SN-ML change from 
baseline (follow-up: 5.2–15.8 
mos)* 
The SN-ML decreased on average 
by 0.43° per year in the Ctr groups 
(range -1.92° to 0.30°) 
The mean SN-ML increased in the FFA 
groups by 0.48° per year (95% CI: 0.04°–
0.92° increase) compared to the Ctr groups 360 (8) 
⊕⊕⊖⊖ 
Low 
– 
Annualized 1s-SN change from 
baseline (follow-up: 5.2–15.8 
mos)* 
The 1s-SN increased on average by 
0.93° per year in the Ctr groups 
(range 0.40° to 3.06°) 
The mean 1s-SN decreased in the FFA 
groups by 7.50° per year (95% CI: 4.11°–
10.88° decrease) compared to the Ctr groups 262 (6) 
⊕⊕⊕⊕ 
Very high** 
Effect magnitude affected 
by (i) patient’s skeletal 
growth stage and (ii) 
construction bite 
Annualized 1i-ML change from 
baseline (follow-up: 5.2–15.8 
mos)* 
The 1i-ML increased on average 
by 0.25° per year in the Ctr groups 
(range -0.80° to 1.00°) 
The mean 1i-ML increased in the FFA 
groups by 7.99° per year (95% CI: 3.56°–
12.42° increase) compared to the Ctr groups 418 (9) 
⊕⊕⊕⊕ 
Very high** 
Effect magnitude affected 
by (i) patient’s skeletal 
growth stage and (ii) 
appliance 
Annualized nasolabial angle 
change from baseline (follow-up: 
5.2–15.8 mos)* 
The nasolabial angle increased on 
average by 0.49° per year in the 
Ctr groups (range -1.34° to 1.81°) 
The mean nasolabial angle increased in the 
FFA groups by 0.03° per year (95% CI: 
2.39° decrease–2.45° increase) compared to 
the Ctr groups 210 (5) 
⊕⊕⊖⊖ 
Low 
– 
All judgements start from “low”, due to the vast inclusion of non-randomized studies. 
*From cephalometric analysis. 
**Upgraded by two for effect magnitude; very large effect (cephalometric norm + 2 SDs + 1° for method error), which was included in the mean effect, the confidence interval and the 
prediction interval, while no serious limitations were found. Furthermore, magnitude of incisor inclination change significantly associated with duration of functional appliance treatment. 
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Table 6. Details of the performed subgroup analyses. MD, mean difference; CI, confidence interval; PSG, P values for difference between subgroups; FFRD, Forsus 
Fatigue Resistant Device; FLMGM, Fixed Lingual Mandibular Growth Modificator; FNFS, Forsus Nitinol Flat Spring; JJ, Jasper Jumper; SUS, Sabbagh Universal 
Spring; SM, Sydney Magnoglide; SS, stainless steel. 
  SNA n=11 SNB n=11 ANB n=11 NA-APg n=6 SN-ML n=10 
 n MD (95% CI) PSG n MD (95% CI) PSG n MD (95% CI) PSG n MD (95% CI) PSG n MD (95% CI) PSG 
Patient-related                
Gender ratio 11  0.190 11  0.710 11  0.080 6  0.002 10  0.368 
Skeletal growth 
stage                
 
Pre-peak and 
peak 3 -0.92 (-1.35,-0.50) 0.316 3 1.23 (-0.12,2.57) 0.401 3 -2.05 (-3.43,-0.67) 0.218 2 -4.89 (-9.21,-0.57) 0.135 3 0.46 (-0.09,1.00) 0.440 
 Post-peak 4 -0.11 (-1.81,1.59)  4 0.48 (-0.31,1.27)  4 -0.49 (-2.03,1.06)  4 0.72 (-3.06,4.50)  4 0.95 (-0.07,1.98)  
Appliance-related                
Appliance                
 FFRD 2 1.31 (0.00,2.62) 0.284 2 0.43 (-0.65,1.49) 0.082 2 0.94 (-0.42,2.30) 0.017 2 4.08 (1.38,6.78) 0.060 2 1.41 (-0.39,3.21) 0.881 
 FLMGM 1 -0.90 (-1.62,-0.18)  1 2.84 (1.98,3.70)  1 -3.59 (-4.35,-2.83)  1 -7.16 (-8.93,-5.39)  1 0.30 (-0.92,1.52)  
 FNFS 1 -1.48 (-7.22,4.26)  1 4.37 (-1.02,9.76)  1 -7.19 (-9.67,-4.71)     1 -0.43 (-9.76,8.90)  
 Herbst 3 -0.75 (-1.27,-0.23)  3 0.55 (0.24,0.86)  3 -1.22 (-1.58,-0.86)  1 -2.75 (-3.79,-1.71)  2 0.50 (-0.12,1.11)  
 JJ 1 -1.27 (-6.82,4.28)  1 2.62 (-2.40,7.64)  1 -4.32 (-6.41,-2.23)     1 -1.83 (-9.22,5.56)  
 SUS 2 -1.64 (-3.18,-0.09)  2 0.55 (-0.63,1.72)  2 -1.77 (-2.90,-0.64)  2 -2.54 (-5.13,0.05)  2 0.74 (-0.51,1.98)  
 SM 1 -1.30 (-2.01,-0.59)  1 0.60 (-0.15,1.35)  1 -1.60 (-2.18,-1.02)     1 0.20 (-0.75,1.15)  
Herbst design                
 SS crown 1 -0.50 (-1.08,0.08) 
0.095
* 1 0.70 (0.22,1.18) 
0.607
* 1 -1.10 (-1.55,-0.65) 
0.236
*       
 Cast splint 1 -1.17 (-1.61,-0.74)  1 0.35 (-0.15,0.85)  1 -1.63 (-2.20,-1.06)     1 0.56 (-0.23,1.35) 
0.802
* 
 Modified 1 -0.40 (-1.20,0.40)  1 0.60 (-0.06,1.26)  1 -1.00 (-1.54,-0.46)     1 0.40 (-0.57,1.37)  
Construction bite                
 Single step 2 -0.86 (-1.60,-0.12) 0.444 2 0.44 (0.04,0.84) 0.452 2 -1.31 (-1.92,-0.69) 0.765 1 -2.75 (-3.79,-1.71) 0.436 2 0.50 (-0.12,1.11) 0.542 
 Stepwise 7 -0.27 (-1.20,0.66)  7 0.68 (0.27,1.09)  7 -1.89 (-3.37,-0.40)  4 0.72 (-3.06,4.50)  6 0.89 (-0.12,1.89)  
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Table 6. (continued) 
 
  SN-NL n=8 1s-SN n=8 1i-ML n=11 Nasolabial angle n=6 
  n MD (95% CI) PSG n MD (95% CI) PSG n MD (95% CI) PSG n MD (95% CI) PSG 
Patient-related             
 Gender ratio 8  0.168 8  0.497 11  0.377 6  0.104 
Skeletal growth stage             
 
Pre-peak 
and peak 2 0.06 (-0.47,0.59) 0.052 1 -4.24 (-6.19,-2.30) 0.035 3 0.16 (-5.12,5.43) 0.010 2 0.51 (-5.05,6.07) 0.824 
 Post-peak 4 1.93 (0.70,3.17)  4 -10.92 (-13.92,-7.92)  4 18.89 (12.50,25.28)  4 -0.44 (-3.64,2.76)  
Appliance-related             
Appliance             
 FFRD 2 1.60 (0.08,3.11) 0.397 2 -10.60 (-15.89,-5.30) 0.151 2 24.51 (21.59,27.43) 0.002 2 -2.75 (-6.45,0.96) 0.348 
 FLMGM 1 0.00 (-0.63, 0.63)     1 -6.72 (-9.88,-3.56)     
 FNFS 1 -1.79 (-6.55,2.97)  1 -11.54 (-17.93,-5.15)  1 11.03 (5.47,16.59)     
 Herbst 1 0.20 (-0.78,1.18)  1 -4.24 (-6.19,-2.30)  3 3.92 (2.25,5.59)  2 0.51 (-5.05,6.07)  
 JJ 1 0.03 (-4.21,4.27)  1 -12.03 (-20.39,-3.67)  2 16.15 (6.07,26.23)     
 SUS 2 2.59 (0.46,4.72)  2 -11.07 (-14.71,-7.44)  2 13.31 (9.95,16.67)  2 3.01 (-1.71,7.73)  
 SM    1 -2.20 (-4.24,-0.16)  1 0.40 (-1.05,1.85)     
Herbst design             
 SS crown       1 5.40 (3.38,7.42) 
0.102
*   
0.084
* 
 cast splint       1 2.74 (1.33,4.15)  1 -2.15 (-6.26,1.96)  
 modified       1 4.00 (1.58,6.42)  1 3.54 (-1.45,8.53)  
Construction bite             
 Single step 1 0.20 (-0.78,1.18) 0.135 1 -4.24 (-6.19,-2.30) 0.009 2 3.06 (1.84,4.28) 0.057 2 0.51 (-5.05,6.07) 0.824 
 Stepwise 6 1.57 (0.42,2.72)  6 -11.13 (-13.71,-8.55)  7 15.34 (8.39,22.30)  4 -0.44 (-3.64,2.76)  
Bold values indicate statistically significant differences between subgroups. 
*Mixed-effects subgroup analysis not possible, due to the small sample. Conventional inverse variance subgroup analysis reported. 
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Supplementary table 1 Electronic databases searched, search strategies used and corresponding results. 
Electronic database Search strategy used Limits Hits 
 
MEDLINE  
Searched via PubMed (1950 - week 1, October 
2014) 
http://www.ncbi.nlm.nih.gov/pubmed/advanced 
 
 
((((((maxill* AND (excess* OR prognath*)) OR (mandib* AND (deficien* OR retrognath* OR reposition* OR enhanc* OR advanc*)) OR 
functional OR orthopaedic* OR orthopedic* OR growth)) OR (Herbst OR "Magnetic telescopic device" OR "Ventral telescope" OR 
"Mandibular advancing repositioning splint" OR "Mandibular corrector appliance" OR "Biopedic appliance" OR "Ritto appliance" OR 
"Mandibular protraction appliance" OR "Mandibular anterior repositioning appliance" OR "MARA" OR "Functional mandibular advancer" OR 
"Jasper jumper" OR "Scandee tubular jumper" OR "Flex developer" OR "Adjustable bite corrector" OR "Bite fixer" OR "Forsus nitinol flat 
spring" OR "Forsus device" OR "Forsus appliance" OR "Twin force bite corrector" OR "Eureka spring" OR "Sabbagh spring" OR Activator 
OR Bionator OR "Bimler appliance" OR "Fraenkel appliance" OR "Frankel appliance" OR "Bass appliance" OR "Harvold appliance" OR 
"Andresen appliance" OR "Teuscher appliance" OR "Stoeckli appliance" OR "Stockli appliance" OR Biobloc OR "Bite jumper" OR "Bite 
jumping" OR "SII appliance" OR "Twin block")) AND ("class ii malocclusion" OR class ii div* OR class ii/* OR ("class ii" AND 
orthodont*)))) AND ((randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized controlled trials[mh] OR random 
allocation[mh] OR double-blind method[mh] OR single-blind method[mh] OR clinical trial[pt] OR clinical trials[mh]) OR ("clinical trial"[tw]) 
OR ((singl*[tw] OR doubl*[tw] OR trebl*[tw] OR tripl*[tw]) AND (mask*[tw] OR blind*[tw])) OR (placebos[mh] OR placebo*[tw] OR 
random*[tw] OR research design[mh:noexp] OR comparative study OR evaluation studies OR follow-up studies[mh] OR prospective 
studies[mh] OR control*[tw] OR prospectiv*[tw] OR volunteer*[tw])) 
 
 
No limitations 
 
1493 
EMBASE 
Searched via embase biomedical answers 
(<1966 – week 1, October 2013) 
http://www.embase.com/search/advanced 
(maxill* AND (excess* OR prognath*)) OR (mandib* AND (deficien* OR retrognath* OR reposition* OR enhanc* OR advanc*)) OR 
functional OR orthopaedic* OR orthopedic* OR 'growth'/exp OR herbst OR 'magnetic telescopic device' OR 'ventral telescope' OR 'mandibular 
advancing repositioning splint' OR 'mandibular corrector appliance' OR 'biopedic appliance' OR 'ritto appliance' OR 'mandibular protraction 
appliance' OR 'mandibular anterior repositioning appliance' OR 'mara' OR 'functional mandibular advancer' OR 'jasper jumper' OR 'scandee 
tubular jumper' OR 'flex developer' OR 'adjustable bite corrector' OR 'bite fixer' OR 'forsus nitinol flat spring' OR 'forsus device' OR 'forsus 
appliance' OR 'twin force bite corrector' OR 'eureka spring' OR 'sabbagh spring' OR activator OR bionator OR 'bimler appliance' OR 'fraenkel 
appliance' OR 'frankel appliance' OR 'bass appliance' OR 'harvold appliance' OR 'andresen appliance' OR 'teuscher appliance' OR 'stoeckli 
appliance' OR 'stockli appliance' OR biobloc OR 'bite jumper' OR 'bite jumping' OR 'sii appliance' OR 'twin block' AND ('class ii malocclusion' 
OR class AND ii AND div* OR class AND ii OR ('class ii' AND orthodont*)) AND ('clinical trial'/exp OR 'comparative study'/exp OR 
'controlled clinical trial'/exp OR 'double blind procedure'/exp OR 'prospective study'/exp OR 'randomized controlled trial'/exp) AND 
'malocclusion'/exp 
 
Limitations: Study type: clinical 
trial, comparative study, controlled 
clinical trial, double blind 
procedure, prospective study, 
randomized controlled trial, 
Disease: malocclusion 
 
549 
Cochrane Database of Systematic Reviews 
Searched via The Cochrane Library on October 
10, 2014 
http://onlinelibrary.wiley.com/o/cochrane/cochran
e_search_fs.html?newSearch=true 
(maxill* AND (excess* OR prognath*)) OR (mandib* AND (deficien* OR retrognath* OR reposition* OR enhanc* OR advanc*)) OR 
functional OR orthopaedic* OR orthopedic* OR growth OR (Herbst OR "Magnetic telescopic device" OR "Ventral telescope" OR "Mandibular 
advancing repositioning splint" OR "Mandibular corrector appliance" OR "Biopedic appliance" OR "Ritto appliance" OR "Mandibular 
protraction appliance" OR "Mandibular anterior repositioning appliance" OR "MARA" OR "Functional mandibular advancer" OR "Jasper 
jumper" OR "Scandee tubular jumper" OR "Flex developer" OR "Adjustable bite corrector" OR "Bite fixer" OR "Forsus nitinol flat spring" OR 
"Forsus device" OR "Forsus appliance" OR "Twin force bite corrector" OR "Eureka spring" OR "Sabbagh spring" OR Activator OR Bionator 
OR "Bimler appliance" OR "Fraenkel appliance" OR "Frankel appliance" OR "Bass appliance" OR "Harvold appliance" OR "Andresen 
appliance" OR "Teuscher appliance" OR "Stoeckli appliance" OR "Stockli appliance" OR Biobloc OR "Bite jumper" OR "Bite jumping" OR 
"SII appliance" OR "Twin block") AND ("class ii malocclusion" OR class ii div* OR class ii/ OR ("class ii" AND orthodont*)) 
 
No limitations 628 
Cochrane Central Register of Controlled Trials 
Searched via The Cochrane Library 
on October 10, 2014 
http://onlinelibrary.wiley.com/o/cochrane/cochran
e_search_fs.html?newSearch=true 
 
(maxill* AND (excess* OR prognath*)) OR (mandib* AND (deficien* OR retrognath* OR reposition* OR enhanc* OR advanc*)) OR 
functional OR orthopaedic* OR orthopedic* OR growth OR (Herbst OR "Magnetic telescopic device" OR "Ventral telescope" OR "Mandibular 
advancing repositioning splint" OR "Mandibular corrector appliance" OR "Biopedic appliance" OR "Ritto appliance" OR "Mandibular 
protraction appliance" OR "Mandibular anterior repositioning appliance" OR "MARA" OR "Functional mandibular advancer" OR "Jasper 
jumper" OR "Scandee tubular jumper" OR "Flex developer" OR "Adjustable bite corrector" OR "Bite fixer" OR "Forsus nitinol flat spring" OR 
"Forsus device" OR "Forsus appliance" OR "Twin force bite corrector" OR "Eureka spring" OR "Sabbagh spring" OR Activator OR Bionator 
OR "Bimler appliance" OR "Fraenkel appliance" OR "Frankel appliance" OR "Bass appliance" OR "Harvold appliance" OR "Andresen 
appliance" OR "Teuscher appliance" OR "Stoeckli appliance" OR "Stockli appliance" OR Biobloc OR "Bite jumper" OR "Bite jumping" OR 
"SII appliance" OR "Twin block") AND ("class ii malocclusion" OR class ii div* OR class ii/ OR ("class ii" AND orthodont*)) 
 
No limitations 959 
2 
 
Google Scholar 
Searched on October 10, 2014 
http://scholar.google.gr/advanced_scholar_search?
hl=en&as_sdt=0,5 
functional AND orthopedic AND orthodontic AND treatment AND malocclusion AND appliance AND appliances AND “class ii”  
 
in Medicine, Pharmacology, and 
Veterinary Science 
1047 
 
Web of Science 
Searched on October 10, 2014 
http://apps.webofknowledge.com/WOS_GeneralS
earch_input.do?last_prod=WOS&SID=P1G3aMpj
DambMDFjp3e&product=WOS&highlighted_tab
=WOS&search_mode=GeneralSearch 
 
TS=(maxill* AND (excess* OR prognath*)) OR TS=(mandib* AND (deficien* OR retrognath* OR reposition* OR enhanc* OR advanc*)) OR 
TS=(functional) OR TS=(orthopaedic*) OR TS=(orthopedic*) OR TS=(growth) OR TS=("Mandibular anterior repositioning appliance") OR 
TS=("Mandibular protraction appliance") OR TS=("Ritto appliance") OR TS=("Biopedic appliance") OR TS=("Mandibular corrector 
appliance") OR TS=("Mandibular advancing repositioning splint") OR TS=("Ventral telescope") OR TS=("Magnetic telescopic device") OR 
TS=(Herbst) OR TS=("Fraenkel appliance") OR TS=("Bimler appliance") OR TS=(Bionator) OR TS=(Activator) OR TS=("Sabbagh spring") 
OR TS=("Eureka spring") OR TS=("Twin force bite corrector") OR TS=("Forsus appliance") OR TS=("Forsus device") OR TS=("Forsus 
nitinol flat spring") OR TS=("Bite fixer") OR TS=("Adjustable bite corrector") OR TS=("Flex developer") OR TS=("Scandee tubular jumper") 
OR TS=("Jasper jumper") OR TS=("Functional mandibular advancer") OR TS=("MARA") OR TS=("Twin block") OR TS=("SII appliance") 
OR TS=("Bite jumping") OR TS=("Bite jumper") OR TS=(Biobloc) OR TS=("Stockli appliance") OR TS=("Stoeckli appliance") OR 
TS=("Teuscher appliance") OR TS=("Andresen appliance") OR TS=("Harvold appliance") OR TS=("Bass appliance") OR TS=("Frankel 
appliance") AND (TS=("class ii malocclusion") OR TS=(class ii div*) OR TS=(class ii/) OR TS=("class ii" AND orthodont*))  
 
in “Dentistry Oral Surgery 
Medicine” 
 
1191 
Evidence-Based Medicine 
Searched on October 10, 2014 
http://ebm.bmj.com/searchall/ 
 
functional AND "class ii" AND orthodont* 
functional AND "class ii": in title or 
abstract orthodont*: anywhere in 
article 
62 
 
Scopus 
Searched on October 10, 2014 
http://www.scopus.com/search/form.url?display=a
dvanced&clear=t&origin=searchbasic&txGid=1lk
b0B3HcbSzUk8cVtIzKL_%3a3 
 
(Herbst OR "Magnetic telescopic device" OR "Ventral telescope" OR "Mandibular advancing repositioning splint" OR "Mandibular corrector 
appliance" OR "Biopedic appliance" OR "Ritto appliance" OR "Mandibular protraction appliance" OR "Mandibular anterior repositioning 
appliance" OR "MARA" OR "Functional mandibular advancer" OR "Jasper jumper" OR "Scandee tubular jumper" OR "Flex developer" OR 
"Adjustable bite corrector" OR "Bite fixer" OR "Forsus nitinol flat spring" OR "Forsus device" OR "Forsus appliance" OR "Twin force bite 
corrector" OR "Eureka spring" OR "Sabbagh spring" OR Activator OR Bionator OR "Bimler appliance" OR "Fraenkel appliance" OR "Frankel 
appliance" OR "Bass appliance" OR "Harvold appliance" OR "Andresen appliance" OR "Teuscher appliance" OR "Stoeckli appliance" OR 
"Stockli appliance" OR Biobloc OR "Bite jumper" OR "Bite jumping" OR "SII appliance" OR "Twin block") AND ("class ii malocclusion" OR 
class ii div* OR class ii/ OR ("class ii" AND orthodont*)) AND (functional OR orthopaedic* OR orthopedic* OR growth) AND (LIMIT-
TO(SUBJAREA, "DENT") OR LIMIT-TO(SUBJAREA, "MULT"))  
 
in Dentistry 
 
1749 
LILACS database 
Searched on October 10, 2014 
http://bases.bireme.br/cgi-
bin/wxislind.exe/iah/online/?IsisScript=iah/iah.xis
&base=LILACS&lang=i 
 
 
orthodont$ or angle class ii and functional  
 
 
in Words 
 
389 
Bibliografia Brasileira de Odontolgogia 
Searched on October 10, 2014 
http://bases.bireme.br/cgi-
bin/wxislind.exe/iah/online/?IsisScript=iah/iah.xis
&base=BBO&lang=i 
 
orthodont$ or angle class ii and functional  in Words 
219 
 
Ovid database  
Searched via HEAL-Link on October 10, 2014 
http://ovidsp.tx.ovid.com/sp-
3.4.2a/ovidweb.cgi?&S=LCNCFPPJBPDDFDPJN
CBLAFFBMDFPAA00&New+Database=Single
%7c2 
((maxill* and (excess* or prognath*)) or (mandib* and (deficien* or retrognath* or reposition* or enhanc* or advanc*)) or functional or 
orthopaedic* or orthopedic* or growth or (Herbst or "Magnetic telescopic device" or "Ventral telescope" or "Mandibular advancing 
repositioning splint" or "Mandibular corrector appliance" or "Biopedic appliance" or "Ritto appliance" or "Mandibular protraction appliance" or 
"Mandibular anterior repositioning appliance" or "MARA" or "Functional mandibular advancer" or "Jasper jumper" or "Scandee tubular 
jumper" or "Flex developer" or "Adjustable bite corrector" or "Bite fixer" or "Forsus nitinol flat spring" or "Forsus device" or "Forsus 
appliance" or "Twin force bite corrector" or "Eureka spring" or "Sabbagh spring" or Activator or Bionator or "Bimler appliance" or "Fraenkel 
appliance" or "Fränkel appliance" or "Frankel appliance" or "Bass appliance" or "Harvold appliance" or "Andresen appliance" or "Teuscher 
appliance" or "Stoeckli appliance" or "Stockli appliance" or Biobloc or "Bite jumper" or "Bite jumping" or "SII appliance" or "Twin 
in title, abstract, full text, caption 
text 
276 
3 
 
block")).mp. and (("class ii malocclusion" or class ii div*).mp. or class ii/ or ("class ii" and orthodont*).mp.)  
Bandolier 
Searched on October 10, 2014 
http://www.medicine.ox.ac.uk/bandolier/bformHJ.
html 
 
 
orthodontic 
 
 
No limitations 
 
1 
Atypon Link 
Searched on November 12, 2011* 
http://www.atypon-link.com/ 
 
orthodont* No limitations 16 
African Journals Online 
Searched on October 10, 2014 
http://www.ajol.info/index.php/index/search 
 
(functional OR class ii) AND orthodont* No limitations 6 
ProQuest 
Searched on October 10, 2014 
http://proquest.umi.com/pqdweb?RQT=403&TS=
1321887206&clientId=68919 
 
(functional) AND (orthodont*) AND ("class ii")  in Anywhere except full text – ALL 123 
Conference Paper Index 
Searched via Cambridge Scientific Abstracts 
(1919 – October 10, 2014) 
http://journals.cambridge.org/action/advanceSearc
h?sessionId=30DBC2BF08FD26DF4AA4689F04
961599.journals 
 
(functional OR “class ii”) AND orthodont*  in Medicine  169 
German National Library of Medicine (ZB 
MED) 
Searched via MEDPILOT on October 10, 2014 
http://www.medpilot.de/app/65de19b10e83c5faea
497930a5cfb322?LANGUAGE=en 
 
(orthodont* OR "class ii") AND appliance*  in “Catalogue Medicine. Health.” 198 
metaRegister of Controlled Trials  
Searched on October 10, 2014 
http://www.controlled-trials.com/mrct/searchform 
 
(functional OR “class ii”) AND orthodont*  in “all registers” 32 
Sum   9107 
*As of January 2012, Atypon Link is discontinued. 
Supplementary table 2 A classification of the angular cephalometric variables examined in the present 
study, with the various terms used among the selected studies, and their definitions. 
  
 
 
 
Term used Other terms Definition 
Angular skeletal cephalometric variables 
SNA Sella-Nasion-Point A The posterior-inferior angle formed by Se, Na and A point 
SNB Sella-Nasion-Point B The inferior-posterior angle defined by Se, Na and B point 
SNPg - The angle formed by Se, Na and Pg 
ANB 
A Point-Nasion-B Point angle, A-B Difference, A-B 
diff 
The angle between Point A, Na and Point B; the difference between angles 
SNA and SNB 
NAPg NAP, Angle of convexity The inferior angle formed by the lines Nasion-A point and A point-Pg 
SGo:Nme (%) Jarabak ratio, Sgo:NM, Sgo:Nme Ratio of posterior to anterior facial height 
SN-ML SN-MP, SN-GoGn, SN-GoMe, ML/NSL, MPA 
The angle formed by the anterior cranial base plane and the mandibular 
plane 
NL-ML 
Maxillary Mandibular Planes angle, ANSPNS-GoGn, 
MM angle, PP-MP, PP-GoMe, PP-GoGn, ANSPNS-
GoMe, SpaSpp-Mgo 
The angle formed by the Palatal line and the Mandibular line 
SN-NL 
Sella Nasion to Palatal Plane, SeNa-ANSPNS, 
NL/NSL, SN-ANS/PNS, SN-SpaSpp, SN-PP, PP 
angle, Palatal plane angle 
The angle between the Sella-Nasion line and the Palatal plane 
SN-OP OL/NSL, OP angle, Occlusal plane angle Angle between Sella-Nasion line and Occlusal plane 
y axis  Angle between Frankfurt Horizontal Plane and S-Gn plane 
 
Angular dental cephalometric variables 
1s-SN - Angle from the upper incisor long axis to the anterior cranial base plane 
1i-ML 
1i-MP, IMPA, Incisor-mandibular plane angle, 
L1GoGn, L1ML, L1MP 
Angle between lower incisor long axis and mandibular plane 
1s-1i Interincisal angle, L1U1, 1/1, 1iW, 1s/1i The angle formed by the long axis of the upper and lower incisors 
1s-NA 1NA, 1/NA, max. central incisor.NA Angle between the upper incisor long axis and the NA line 
1i-NB L1NB, mand. central incisor.NB Angle between lower incisor long axis and the NB line 
1i-VL  
Angle between the upper incisor long axis and a reference line (VL) vertical 
to the Frankfurt Horizontal plane. 
 
Angular soft tissue cephalometric variables 
N΄SnPg΄ Convexity angle excluding the nose The angle formed by N', Sn and Pg' points 
Nasolabial angle CmSnLs Angle between the nasal line and the most anterior point of the upper lip 
Mentolabial angle Li-Sm-Pg' Angle between the line of the lower lip and the Me' 
H angle Holdaway Angle, Na'-Pg'-Ls, H line-Na’Pg’ 
The superior-posterior angle between the H line (the most anterior superior 
point of the soft tissue chin and Labrale superius) and the N’-Pg’ line 
   
Ratios 
ANSMe:Nme LFH/TAFH Ratio of lower facial height to total anterior facial height 
Gonial Ratio - 
The ratio between the upper gonial (NGoAr) and the lower gonial (NGoMe) 
angle 
S-Ar/Ar-Go - Quotient of Ar-Go and S-Ar lines 
Supplementary table 3a Assessment of randomized controlled trials with the Cochrane risk of bias tool. 
A/A Author/year 
Random sequence 
generation 
(selection bias) 
Allocation 
concealment 
(selection bias) 
Blinding of outcome 
assessment (detection 
bias)* 
Incomplete 
outcome data 
(attrition bias) 
Selective 
reporting 
(reporting bias) 
Other bias 
Overall risk of 
bias 
1 Baysal and Uysal (58) Low risk Unclear Unclear High risk Low risk Low risk High risk 
*The domain “blinding of participants and personnel” was not assessed, as it was judged unfeasible. 
Supplementary table 3b Risk of bias for the non-randomized trials, according to the modified Downs and Black tool.  
 
 1 2 3 4 5 6 7 8 
 Author/year Alali (57) 
de Almeida et al, (59) 
and de Almeida et al, 
(60) 
Gunay et al. 
(61) 
Karacay et al. 
(62)  
Latkauskienė (63) 
Oztoprak et 
al. (64) 
Phelan et al. 
(65) 
Uyanlar et 
al. (66) 
R
e
p
o
r
ti
n
g
 
Is the hypothesis/aim/objective of the study clearly described? 1 1 1 1 1 1 1 1 
Are the main outcomes to be measured clearly described in the Introduction 
or Methods section? 
1 1 1 1 1 1 1 1 
Were inclusion and exclusion criteria clearly stated? 1 1 1 1 1 1 1 1 
Are the characteristics of the patients included clearly described? 1 1 1 1 1 1 1 1 
Are the functional appliances used clearly described? 1 1 1 1 1 1 1 1 
Are the distributors of principal confounders in each group of subjects to be 
compared clearly described? 
1 1 0 0 0 0 0 0 
Are the main findings of the study clearly described? 1 1 1 1 1 1 1 1 
Does the study provide estimates of the random variability in the data for the 
main outcomes? 
1 1 1 1 1 1 1 1 
Have all important adverse events that may be a consequence of functional 
appliances been reported? 
1 1 1 1 1 1 1 1 
Have the characteristics of patients lost to follow-up been described? 1 1 0 0 1 0 1 0 
Have actual probability values been reported for the main outcomes except 
where the probability value is less than 0.001? 
1 0 0 1 1 1 0 0 
E
x
te
r
n
a
l 
v
a
li
d
it
y
 
Were the patients asked to participate in the study representative of the entire 
population from which they were recruited? 
1 1 1 1 1 1 1 1 
Were those subjects who were prepared to participate representative of the 
entire population from which they were recruited?  
1 1 1 1 1 1 1 1 
Were the staff, places, and facilities where the patients were treated, 
representative of the treatment the majority of patients receive? 
1 1 1 1 1 1 1 1 
In
te
r
n
a
l 
v
a
li
d
it
y
 -
 
b
ia
s 
Was an attempt made to blind those measuring the main outcome of the 
intervention? 
1 0 0 0 1 0 0 0 
If any of the results of the study were based on “data dredging”, was that 
made clear? 
1 1 1 1 1 1 1 1 
Do the analyses adjust for different lenghts of follow-up of patients? 1 0 0 0 1 0 0 0 
Were the statistical tests used to assess the main outcomes appropriate? 1 1 1 1 1 1 1 1 
Was compliance with the functional appliance used reliable? 1 1 1 1 1 1 1 1 
Were the main outcome measures used accurate (valid and reliable)? 1 1 1 1 1 1 1 1 
In
te
r
n
a
l 
v
a
li
d
it
y
 -
 
c
o
n
fo
u
n
d
in
g
 
Were the patients in different intervention groups recruited from the same 
population? 
1 0 0 1 0 1 0 0 
Were the baseline characteristics comparable? 1 1 0 0 1 1 1 1 
Were study subjects in different intervention groups recruited over the same 
period of time? 
1 0 0 1 0 0 0 0 
Was there adequate adjustment for confounding in the analyses from which 
the main findings were drawn? 
1 0 0 1 0 0 0 0 
Were losses of patients to follow-up taken into account? 0 0 0 0 0 0 0 0 
P
o
w
e
r
 
Did the study have sufficient power to detect a clinically important effect 
where the probability value for a difference being due to chance is less than 
5%? 
3 5 3 3 5 5 5 3 
 
Sum 27 23 18 22 25 23 22 19 
Supplementary table 4 Details for the GRADE assessment of the primary outcomes*. SGs, subgroups; OIS, optimal information size. 
Variable Risk of bias Inconsistency Indirectness Imprecision 
Reporting 
biases 
Effect magnitude Dose response effect 
Residual 
confounding 
SNA 
No clear indication 
to downgrade. 
Low heterogeneity; no reason to 
downgrade 
Directly 
relevant 
Adequate sample 
No evidence 
of bias 
No reason to rate up 
No significant regression 
to treatment duration 
Existing 
SNB 
No clear indication 
to downgrade. 
Moderate heterogeneity, explained by 
SGs and confidence regarding 
decision unaffected 
Directly 
relevant 
Adequate sample 
No evidence 
of bias 
No reason to rate up 
No significant regression 
to treatment duration 
Existing 
ANB 
No clear indication 
to downgrade. 
High heterogeneity, explained by 
SGs; confidence regarding decision 
might be affected 
Directly 
relevant 
Adequate sample 
No evidence 
of bias 
No reason to rate up 
No significant regression 
to treatment duration 
Existing 
SN-ML 
No clear indication 
to downgrade. 
Low heterogeneity; no reason to 
downgrade 
Directly 
relevant 
Adequate sample 
No evidence 
of bias 
No reason to rate up 
No significant regression 
to treatment duration 
Existing 
1s-SN 
No clear indication 
to downgrade. 
High heterogeneity, explained by SGs 
and confidence regarding decision 
unaffected 
Directly 
relevant 
Adequate sample 
No evidence 
of bias 
Rated up by two for very 
large effect, which was 
included in the mean effect, 
the confidence interval and 
the prediction interval, 
while no serious limitations 
were found. 
Significant regression of 
incisor inclination to 
treatment duration 
Existing 
1i-ML 
No clear indication 
to downgrade. 
High heterogeneity, explained by 
SGs; confidence regarding decision 
might be affected 
Directly 
relevant 
Adequate sample 
No evidence 
of bias 
Rated up by two for very 
large effect, which was 
included in the mean effect, 
the confidence interval and 
the prediction interval, 
while no serious limitations 
were found. 
Significant regression of 
incisor inclination to 
treatment duration 
Existing 
Nasolabial angle 
No clear indication 
to downgrade. 
Low heterogeneity; no reason to 
downgrade 
Directly 
relevant 
Inadequate sample (210 patients) 
compared to the OIS (240 
patients); confidence intervals 
includes the null-effect, but not 
large benefit or harm. No clear 
indication of imprecision. 
No evidence 
of bias 
No reason to rate up 
No significant regression 
to treatment duration 
Existing 
*Regarding risk of bias, all outcomes start from "low", due to the inclusion of non-randomized studies; no reason to further downgrade. 
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Supplementary table 5 Sensitivity analysis by meta-regression on the duration of functional appliance treatment. 
Variable P value* 
SNA 0.251 
SNB 0.503 
ANB 0.756 
SN-ML 0.689 
1s-SN 0.054 
1i-ML 0.059 
Nasolabial angle 0.832 
*From meta-regression. Bold values indicate statistically significant results. 
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Supplementary table 6 Sensitivity analysis according to the study design of included studies. RCT, randomized controlled trial; MD, mean difference; CI, 
confidence interval; PSG, P value for differences between subgroups of RCTs and non-RCTs. 
   RCTs  Non-RCTs   
Variable n  n MD (95% CI) P value  n MD (95% CI) P value  PSG 
SNA 9  1 -1.17 (-1.61,-0.74) <0.001  8 -0.71 (-1.09,-0.32) <0.001  0.240 
SNB 9  1 0.35 (-0.15, 0.85) 0.174  8 0.97 (0.30, 1.64) 0.004  0.522 
ANB 9  1 -1.63 (-2.20, -1.06) <0.001  8 -1.76 (-2.67, -0.86) <0.001  0.948 
SN-ML 8  1 0.56 (-0.23, 1.35) 0.165  7 0.45 (-0.08, 0.98) 0.097  0.824 
1s-SN 6  1 -4.24 (-6.19, -2.30) <0.001  5 -8.83 (-14.06, -3.61) 0.001  0.409 
1i-ML 9  1 2.74 (1.33, 4.15) <0.001  8 8.81 (3.14, 14.48) 0.002  0.578 
Nasolabial angle 5  1 -2.15 (-6.26, 1.96) 0.305  4 0.94 (-1.79, 3.67) 0.500  0.307 
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Supplementary figure 1 Meta-analysis of the SNA angle (in °/year) between the FFAs and control 
groups divided into subgroups according to the FFA used. 
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0.70 (0.22, 1.18) 
0.55 (0.24, 0.86) 
2.62 (-2.40, 7.64) 
2.62 (-2.40, 7.64) 
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Supplementary figure 2 Meta-analysis of the SNB angle (in °/year) between the FFAs and control 
groups divided into subgroups according to the FFA used. 
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Supplementary figure 3 Meta-analysis of the ANB angle (in °/year) between the FFAs and control 
groups divided into subgroups according to the FFA used. 
.       (  -  ,  -  ) 
.       (., .) 
.       (., .) 
.       (., .) 
.       (  -  ,  -  ) 
.       (., .) 
Inestimable predictive distribution with <3 studies 
with estimated predictive interval 
with estimated predictive interval 
with estimated predictive interval 
Inestimable predictive distribution with <3 studies 
with estimated predictive interval 
Forsus Fatigue Resistant Device 
Oztoprak 2012 
Gunay 2011 
Subtotal  (I2=0%; P<0.001) 
Forsus Nitinol Flat Spring 
Karacay 2006 
Subtotal  (I2 inestimable; P<0.001) 
Herbst 
Baysal 2011 
Subtotal  (I2 inestimable; P<0.001) 
Jasper Jumper 
Karacay 2006 
Subtotal  (I2 inestimable; P=0.005) 
Sabbagh Universal Spring 
Oztoprak 2012 
Uyanlar 2014 
Subtotal  (I2=0%; P<0.001) 
Sydney Magnoglide 
Phelan 2012 
Subtotal  (I2 inestimable; P=0.035) 
Study 
20 
15 
16 
20 
16 
20 
15 
31 
Nfa 
-7.86 
-8.18 
-11.14 
-2.99 
-11.63 
-8.21 
-8.60 
-3.60 
Mfa 
14.56 
14.02 
9.45 
3.42 
14.49 
7.98 
8.44 
4.50 
SDfa 
19 
12 
16 
20 
16 
19 
12 
30 
Nctr 
3.06 
2.00 
0.40 
1.25 
0.40 
3.06 
2.16 
-1.40 
Mctr 
6.80 
6.52 
9.00 
2.83 
9.00 
6.80 
7.04 
3.60 
SDctr 
-11.54 (-17.93, -5.15) 100.00 
100.00 
100.00 
Weight 
-10.92 (-18.00, -3.84) 
-10.18 (-18.18, -2.18) 
-10.60 (-15.89, -5.30) 
-11.54 (-17.93, -5.15) 
-4.24 (-6.19, -2.29) 
-4.24 (-6.19, -2.29) 
-12.03 (-20.39, -3.67) 
-12.03 (-20.39, -3.67) 
-11.27 (-15.92, -6.62) 
-10.76 (-16.60, -4.92) 
-11.07 (-14.71, -7.44) 
-2.20 (-4.24, -0.16) 
-2.20 (-4.24, -0.16) 
MD (95% CI) 
56.09 
43.91 
100.00 
100.00 
100.00 
100.00 
100.00 
61.25 
38.75 
100.00 
100.00 
    
0 -30 -15 15 30 
1s-SN angle (post-pre) difference between 
FFAs and control groups (°/year) 
Supplementary figure 4 Meta-analysis of the 1s-SN angle (in °/year) between the FFAs and 
control groups divided into subgroups according to the FFA used. 
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Supplementary figure 5 Meta-analysis of the 1i-ML angle (in °/year) between the FFAs and control 
groups divided into subgroups according to the FFA used. 
